SCHEMBL9921371

SCHEMBL9921371

Fc1ccc2ncnc(NCCc3ccccc3Cl)c2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 5/20 0.60
CLK4 Q9HAZ1 4/20 0.54
USP10 Q14694 1/20 0.54
PIK3C3 Q8NEB9 1/20 0.54
USP13 Q92995 1/20 0.54
PIK3CD O00329 2/20 0.51
PIK3R1 P27986 2/20 0.51
HDAC1 Q13547 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
MAPK1 P28482 4/20 0.49
CYP1A2 P05177 3/20 0.49
CYP2D6 P10635 3/20 0.49
CYP3A4 P08684 2/20 0.49
LMNA P02545 2/20 0.49
CYP2C19 P33261 1/20 0.49
HIF1A Q16665 1/20 0.49
CNR1 P21554 1/20 0.49
CNR2 P34972 1/20 0.49
KDM4E B2RXH2 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9921372 0.88 HTT (0.62) HTTUSP10PIK3C3USP13PIK3CD
SCHEMBL7411782 0.85 HTT (0.52) HTTCLK4PIK3CDPIK3R1MAPK1
SCHEMBL13191856 0.85 HTT (0.67) HTTUSP10PIK3C3USP13PIK3CD
SCHEMBL9921376 0.85 HTT (0.60) HTTCLK4USP10PIK3C3USP13
SCHEMBL8482300 0.84 HTT (0.67) HTTPIK3CDPIK3R1MAPK1LMNA
SCHEMBL9921370 0.83 MAPK1 (0.59) HTTCLK4USP10PIK3C3USP13
SCHEMBL9921350 0.83 HTT (0.58) HTTCLK4USP10PIK3C3USP13
SCHEMBL7418430 0.82 EGFR (0.61) CLK4MAPK1CYP1A2CYP2D6CYP3A4
SCHEMBL9921375 0.82 HTT (0.65) HTTUSP10PIK3C3USP13PIK3CD
SCHEMBL9921352 0.80 HTT (0.81) HTTUSP10PIK3C3USP13PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY (CN) 2012-10-11 US disclosed
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY (CN) 2012-10-11 US disclosed
WO-2012079079-A1 PRODUCTION OF INDUCED PLURIPOTENT STEM CELLS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-06-14 WO disclosed
WO-2011011522-A2 POTENT SMALL MOLECULE INHIBITORS OF AUTOPHAGY, AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2011-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof ATG7, BECN1, SQSTM1 HTT 4078/4885CLK4 2339/4885USP10 1695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.